Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00890149 · ClinicalTrials.gov registry record · Phase 2
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT00890149 is a Phase 2 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 74 participants.
The verdict
NCT00890149, a Phase 2 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of ondansetron + BASICS Plus in reducing severe or binge drinking among emerging adults. BASIC Plus (Brief Alcohol Screening and Intervention for College Students) has been the most validated brief intervention among college students. The BASICS program provides personal feedback, motivation, and strategies that enhance normative drinking patterns
Interventions
- DRUG Placebo
- DRUG Ondansetron
- BEHAVIORAL BASICS Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00890149
The ClinicalTrials.gov registry entry for NCT00890149 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00890149 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00890149 about?
NCT00890149 is a clinical study titled "Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults". This study will evaluate the efficacy of ondansetron + BASICS Plus in reducing severe or binge drinking among emerging adults. BASIC Plus (Brief Alcohol Screening and Intervention for College Students) has been the most validated brief intervention among college students. The BASICS program provides...
What is the current status of trial NCT00890149?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2015-09. Estimated completion is 2017-03.
What interventions are being tested in trial NCT00890149?
The interventions under investigation include: Placebo (DRUG), Ondansetron (DRUG), BASICS Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT00890149?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.